UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

An unexpected cause of terminal ileitis

Gastrointestinal endoscopy, 2017-02, Vol.85 (2), p.453-453

2017

Volltextzugriff (PDF)

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy

Digestive diseases and sciences, 2023-07, Vol.68 (7), p.2936-2945

2023

Volltextzugriff (PDF)

No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis

Clinical gastroenterology and hepatology, 2020-07, Vol.18 (8), p.1777-1784.e2

2020

Volltextzugriff (PDF)

Real‐life study of safety of thiopurine‐allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

Alimentary pharmacology & therapeutics, 2019-08, Vol.50 (4), p.407-415

2019

Volltextzugriff (PDF)

Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease

Inflammatory bowel diseases, 2017-01, Vol.23 (1), p.75-81

2017

Volltextzugriff (PDF)

Mo1894 Gender Differences in Adalimumab Continuation Rates, Results of a Prospective Crohn's Disease Cohort

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S809-S809

2016

Volltextzugriff (PDF)

Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients

Alimentary pharmacology & therapeutics, 2020-06, Vol.51 (12), p.1353-1364

2020

Volltextzugriff (PDF)

6‐methylmercaptopurine‐induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients

Journal of gastroenterology and hepatology, 2017-06, Vol.32 (6), p.1183-1190

2017

Volltextzugriff (PDF)

Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease

Journal of clinical gastroenterology, 2019-05, Vol.53 (5), p.395

2019

Volltextzugriff (PDF)

Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease

Therapeutic drug monitoring, 2015-12, Vol.37 (6), p.797

2015

Volltextzugriff (PDF)

Practical Guideline for Fatigue Management in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2016-01, Vol.10 (1), p.105-111

2016

Volltextzugriff (PDF)

Sa1691 - Monitoring of Laboratory Parameters During Thiopurine Maintenance Therapy in Patietns with Inflammatory Bowel Disease: An Unnecessary Burden?

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-358-S-358

2018

Volltextzugriff (PDF)

Sa1772 – Prevalence of Cervical Dysplasia in Women with Inflammatory Bowel Disease: Data from the Parelsnoer Institute (PSI) and Palga Database (PAP-IBD Study)

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-396-S-396

2019

Volltextzugriff (PDF)

Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease

Journal of clinical gastroenterology, 2017-12, p.1

2017

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(14)

Sprache

Englisch
(14)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Gastroenterology & Hepatology
(9)
Humans
(8)
Adult
(6)
Female
(6)
Inflammatory Bowel Disease
(6)
Male
(6)
Middle Aged
(5)
Inflammatory Bowel Diseases
(4)
Mercaptopurine - Adverse Effects
(4)
Retrospective Studies
(4)
Young Adult
(4)
Aged
(3)
Azathioprine
(3)
Immunosuppressive Agents - Adverse Effects
(3)
Inflammatory Bowel Diseases - Drug Therapy
(3)
Intestine
(3)
Myelosuppression
(3)
Patients
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An unexpected cause of terminal ileitis

Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy

No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis

Real‐life study of safety of thiopurine‐allopurinol combination therapy in inflammatory bowel disease: myelotoxicity and hepatotoxicity rarely affect maintenance treatment

Sex Is Associated with Adalimumab Side Effects and Drug Survival in Patients with Crohn's Disease

Mo1894 Gender Differences in Adalimumab Continuation Rates, Results of a Prospective Crohn's Disease Cohort

Limited added value of laboratory monitoring in thiopurine maintenance monotherapy in inflammatory bowel disease patients

6‐methylmercaptopurine‐induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients

Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease

Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease

Practical Guideline for Fatigue Management in Inflammatory Bowel Disease

Sa1691 - Monitoring of Laboratory Parameters During Thiopurine Maintenance Therapy in Patietns with Inflammatory Bowel Disease: An Unnecessary Burden?

Sa1772 – Prevalence of Cervical Dysplasia in Women with Inflammatory Bowel Disease: Data from the Parelsnoer Institute (PSI) and Palga Database (PAP-IBD Study)

Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease

Suchergebnisse filtern